Description

Enazumide Capsules 40mg contains Enzalutamide 40mg, a prescription androgen receptor inhibitor used in the treatment of prostate cancer. It works by blocking the effects of male hormones (androgens), such as testosterone, which can promote the growth of prostate cancer cells. Enzalutamide is commonly prescribed for eligible patients with advanced or metastatic prostate cancer under the supervision of an experienced oncologist. Enazumide is taken orally as directed by a healthcare professional. The dosage and duration of treatment depend on the patient's condition, stage of disease, and overall treatment plan. Key Benefits Contains Enzalutamide 40mg, an androgen receptor inhibitor. Helps inhibit the growth and spread of prostate cancer cells. Oral capsule formulation for convenient daily administration. Used as part of established prostate cancer treatment strategies. Manufactured according to high pharmaceutical quality standards. Indications Enazumide Capsules 40mg may be prescribed for the treatment of: Metastatic Castration-Resistant Prostate Cancer (mCRPC) Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) Metastatic Castration-Sensitive Prostate Cancer (mCSPC) Treatment is initiated and monitored by an oncology specialist based on the patient's clinical condition and current treatment guidelines. Administration Take orally once daily, exactly as prescribed by your healthcare provider. Swallow the capsules whole with water; do not crush, chew, or open them. Can be taken with or without food. Continue treatment unless instructed otherwise by your physician. Regular monitoring and follow-up appointments are important throughout therapy.